Medtronic plc (MDT) — ESG & Values Scores

Environment story

Medtronic discloses limited direct Scope 1 and Scope 2 emissions data in source documents; Scope 3 emissions (supply chain, product use) are not transparently reported. Net-zero target year is undisclosed in provided materials. The company references a 2025 Impact Report for environmental details but does not quantify decarbonization infrastructure investments or renewable energy percentage in the 10-K. No major environmental controversies (toxic waste, water, habitat litigation) are documented in the filings. Absence of concrete Scope 3 disclosure and clear net-zero commitment triggers mandatory penalties under the rubric.

Criticisms on file

No material criticisms on file for this pillar.

Disclosed initiatives

Sustainability Reporting

Company references a 2025 Impact Report available on its website; however, specific environmental metrics, carbon reduction targets, and net-zero commitments are not detailed in the 10-K or proxy filings provided.

Social story

Medtronic workforce comprises over 95,000 full-time employees, 43% U.S./Puerto Rico-based. The company reports 100% pay equity for gender and ethnicity in the U.S. and 99% globally. No active documented union-suppression activities or major strikes in the last 24 months are disclosed. Leadership diversity metrics are not quantitatively stated in provided materials; board composition shows multiple female and diverse directors (Fonseca, Goldsmith, Lee, Nabel, Powell represent gender/ethnic diversity), but specific executive/overall leadership diversity percentage is undisclosed. Supply-chain human-rights audit results are not detailed; the company does not disclose specific policies on cobalt or conflict minerals. CEO-to-median-worker pay ratio is not disclosed. Overall, demonstrated pay equity commitment and diverse board representation are positive, but absence of quantified leadership diversity and supply-chain audit transparency creates deductions.

Criticisms on file

No material criticisms on file for this pillar.

Disclosed initiatives

Pay Equity Achievement

Company reports 100% pay equity for gender and ethnically diverse employees in the U.S. and 99% globally; actively working to resolve remaining inequities via annual pay-equity analyses by country.

Addresses gender and racial pay-gap concerns; demonstrates commitment to wage parity.
Inclusion and Diversity Programs

Employee Resource Groups (ERGs) and Diversity Networks provide career development and networking; commitment to inclusive, diverse, equitable workplace; employee engagement survey shows 87% response rate (FY2026).

Supports employee belonging and cultural inclusion.
Skills-Based Hiring and MAPS Program

Shifted from degree requirements to skills-based certification; launched MAPS (Medtronic Advancement Pathways and Skill-building) for U.S./Puerto Rico employees to access undergraduate education at no cost.

Expands talent pipeline and addresses educational barriers to advancement.
Employee Health and Safety Support

Comprehensive Employee Assistance Program and Employee Emergency Assistance Fund (funded by employees and Medtronic Foundation) provide mental health, safety, and financial support; $3 million distributed over last five years.

Demonstrates employee well-being commitment during crises and hardship.

Governance story

Medtronic plc maintains a single-class share structure (no dual-class voting) with ordinary shares conferring equal voting rights. Board independence is strong: 11 of 12 nominees are independent (92% independence), significantly exceeding the 75% threshold; only CEO Martha is non-independent. Board includes diverse expertise (executive leadership, finance, healthcare, technology, legal/regulatory). Lead Independent Director (Craig Arnold, retired CEO of Eaton) provides robust oversight. Board undergoes annual evaluation; directors stand for one-year terms and majority voting applies. Lobbying expenditure and specific policy positions on environmental deregulation are not quantified in filings. No active antitrust, consumer-safety, or financial-fraud regulatory proceedings are disclosed; no shareholder lawsuits targeting climate proposals are documented. Governance structure is well-designed with strong independence, regular elections, and clear committee responsibilities. Absence of quantified lobbying data and no disclosure of environmental-deregulation lobbying alignment prevent perfect score.

Criticisms on file

No material criticisms on file for this pillar.

Disclosed initiatives

Board Diversity and Independence Policy

Formal Board Diversity Policy codifies commitment to diversity of skillset, knowledge, and background. 92% of board is independent. Mandatory retirement at age 75; average tenure 6.5 years; average age 64.

Ensures fresh perspectives and reduces entrenchment; diversity supports multiple viewpoints on ESG and strategic decisions.
Lead Independent Director and Committee Structure

Craig Arnold serves as Lead Independent Director (Chair of Nominating and Corporate Governance Committee); robust committee oversight (Audit, Compensation and Talent, Quality, Growth, Operations, Nominating and Corporate Governance). Regular executive sessions of independent directors.

Strong independent oversight; clear separation of CEO and board chair roles; independent director leadership on key committees.
Annual Director Elections and Majority Voting

All directors stand for one-year terms; majority voting standard for director election; annual board and committee evaluation process.

Shareholders can hold directors accountable annually; regular performance review ensures alignment with shareholder interests.
Sustainability Oversight

Nominating and Corporate Governance Committee oversees corporate social responsibility, sustainability, and impact on employees, citizens, communities, and environment.

Board-level accountability for ESG strategy and execution.
Political Contribution Transparency

Company reviews corporate political contributions and philanthropic activities through the Nominating and Corporate Governance Committee; Principles of Corporate Governance and Political Contribution Policy disclosed.

Transparency on lobbying and political alignment; alignment with public commitments.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Medtronic plc. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Medtronic plc in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)